← Back to Clinical Trials
Recruiting NCT04978168

NCT04978168 Opioid Treatment and Peer Recovery Support

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04978168
Status Recruiting
Phase
Sponsor Brown University
Condition Opioid-use Disorder
Study Type INTERVENTIONAL
Enrollment 450 participants
Start Date 2021-03-02
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Core InterventionPeer Support Specialists (PSS)Treatment as Usual (TAU)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 450 participants in total. It began in 2021-03-02 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Determine whether a facilitated local change team intervention improves a probation organization's client-level medication for opioid use disorder (MOUD) outcomes and implementation outcomes relative to baseline across multiple sites. Determine whether client-level outcomes are further enhanced by the introduction of Peer Support Services.

Eligibility Criteria

Inclusion Criteria: * Community Provider Staff: Any front-line treatment provider at an agency participating in this study who: (a) provides support to MOUD clients, (b) has an active caseload including some individuals on probation, and (c) willing to commit to 12 months to the project. * Probation/Parole Staff: Any probation officer (PO) at an agency participating in this study who (a) has an active caseload, and (b) is willing to commit to 12 months to the project. * Individuals on Probation: (a) 18 years or older, (b) committed to probation within 90 days prior to study enrollment, (c) English speaking, (d) diagnosed with OUD, (e) have stable method of contact in community Exclusion Criteria: * Individuals on Probation: Currently incarcerated or in a court-mandated inpatient treatment.

Contact & Investigator

Central Contact

Rosemarie A Martin, PhD

✉ Rosemarie_Martin@brown.edu

📞 401-863-6656

Principal Investigator

Rosemarie A Martin, PhD

PRINCIPAL INVESTIGATOR

Brown University

Frequently Asked Questions

Who can join the NCT04978168 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid-use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04978168 currently recruiting?

Yes, NCT04978168 is actively recruiting participants. Contact the research team at Rosemarie_Martin@brown.edu for enrollment information.

Where is the NCT04978168 trial being conducted?

This trial is being conducted at Durham, United States, Philadelphia, United States, Providence, United States.

Who is sponsoring the NCT04978168 clinical trial?

NCT04978168 is sponsored by Brown University. The principal investigator is Rosemarie A Martin, PhD at Brown University. The trial plans to enroll 450 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology